Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study

Isfort, Susanne; Hochhaus, Andreas; Brümmendorf, Tim Henrik; Teichmann, Lino L.; Koschmieder, Steffen; Wolf, Dominik; Wolber, Uta; Franke, Georg-Nikolaus; Ernst, Thomas; Crysandt, Martina; Giagounidis, Aristoteles; Stegelmann, Frank; Fabarius, Alice; Pfirrmann, Markus; Pfeiffer, Tim; Al-Ali, Haifa Kathrin; Schafhausen, Philippe; Kiani, Alexander; Hänel, Mathias; Kohn, Denise; Saussele, Susanne; Manz, Kirsi; Burchert, Andreas; Illmer, Thomas; Warnken-Uhlich, Mareille; German CML study group; Göthert, Joachim R.

doi:10.1007/s00277-023-05394-0

Information
References (0)
Discussion (0)
Files

Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study - RWTH-2023-08981

Similar records

h1

h2

h3

h4

h5

h6

RWTH

Kontakt

RWTH Publications

Allgemeines